Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emma R. Veldman"'
Autor:
Haitang Jiang, Emma R. Veldman, Mikael Tiger, Carl-Johan Ekman, Johan Lundberg, Per Svenningsson
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
BackgroundEvidence demonstrates that brain-derived neurotrophic factor (BDNF) and S100 calcium-binding protein B (S100B) have a pivotal role in the pathogenesis of major depressive disorder (MDD) and they are proposed as predictors of antidepressant
Externí odkaz:
https://doaj.org/article/eee5bae671214392af1fa31c85f14e4d
Autor:
Emma R. Veldman, Johan Lundberg, Marie Svedberg, Balázs Gulyás, Andrea Varrone, Mikael Tiger, Katarina Varnäs, Zsolt Cselényi, Christer Halldin
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 42:630-641
The serotonin 1B (5-HT1B) receptor has lately received considerable interest in relation to psychiatric and neurological diseases, partly due to findings based on quantification using Positron Emission Tomography (PET). Although the brainstem is an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de40bcc3a2563fe632db35361fce5d83
https://doi.org/10.1177/0271678x211049185
https://doi.org/10.1177/0271678x211049185
Autor:
Mikael Tiger, Haitang Jiang, Johan Lundberg, Emma R. Veldman, Per Svenningsson, Dejan Mamula, Carl-Johan Ekman
Publikováno v:
Journal of Affective Disorders. 290:240-244
Background Ketamine can act as antidepressant in patients with major depressive disorder (MDD) who are treatment-resistant. P11 has been implicated in ketamine's mechanism of action and proposed as biomarker for treatment response to other antidepres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1578d2849ddf03cdb91c1dceea9b3155
https://doi.org/10.1016/j.jad.2021.04.055
https://doi.org/10.1016/j.jad.2021.04.055
Autor:
Emma R. Veldman, Per Svenningsson, Johan Lundberg, Christer Halldin, Mikael Tiger, Carl Johan Ekman
Publikováno v:
Translational Psychiatry
Translational Psychiatry, Vol 10, Iss 1, Pp 1-8 (2020)
Translational Psychiatry, Vol 10, Iss 1, Pp 1-8 (2020)
The glutamate N-methyl-d-aspartate receptor antagonist ketamine has a rapid antidepressant effect. Despite large research efforts, ketamine’s mechanism of action in major depressive disorder (MDD) has still not been determined. In rodents, the anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d17a945b4deeee8a8b08d5cd8a12fcf
https://doi.org/10.1038/s41398-020-0844-4
https://doi.org/10.1038/s41398-020-0844-4
Publikováno v:
European Neuropsychopharmacology. 27:504-514
The serotonin 1B receptor has recently received more interest as a possible new target for pharmacological treatment of psychiatric disorders. However, the exact mechanisms of action remain unclear. This study aimed to examine the binding distributio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfccb56eefa27ae807662f1f3f563070
https://doi.org/10.1016/j.euroneuro.2017.02.011
https://doi.org/10.1016/j.euroneuro.2017.02.011
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 27(5)
The serotonin 1B receptor has recently received more interest as a possible new target for pharmacological treatment of psychiatric disorders. However, the exact mechanisms of action remain unclear. This study aimed to examine the binding distributio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d5c80f2b7228de324ab47c9597b7b46c
https://pubmed.ncbi.nlm.nih.gov/28318898
https://pubmed.ncbi.nlm.nih.gov/28318898